Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas

Gentleman R: R: A language for data analysis and graphics

Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747 · see citing works

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592 · see citing works

Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers

Kaghad, M., Bonnet, H., Yang, A., Créancier, L., Biscan, J.-C., Valent, A., Minty, A. J., Chalon, P., Lélias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,630 · see citing works

p73 is a human p53-related protein that can induce apoptosis

Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948 · see citing works

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

Doane, A. S., Danso, M. A., Lal, P., Donaton, M., Zhang, L., Hudis, C. A., & Gerald, W. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209415 · Cited by 604 · see citing works

Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer

Peters, A. A., Buchanan, G., Ricciardelli, C., Bianco‐Miotto, T., Centenera, M. M., Harris, J. M., Jindal, S., Segara, D., Li, J., Moore, N. L. T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0452 · Cited by 406 · see citing works

Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer

Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Liu, X. S., & Brown, M. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 398 · see citing works

Androgens induce divergent proliferative responses in human breast cancer cell lines

Birrell, S. N., Bentel, J. M., Hickey, T. E., Ricciardelli, C., Weger, M. A., Horsfall, D. J., & Tilley, W. D. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00005-k · Cited by 245 · see citing works

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

Loibl, S., Müller, B. M., von Minckwitz, G., Schwabe, M., Roller, M., Darb‐Esfahani, S., Ataseven, B., du Bois, A., Fissler-Eckhoff, A., Gerber, B., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1715-8 · Cited by 212 · see citing works

Androgen Receptor Expression in Estrogen Receptor-Negative Breast Cancer Immunohistochemical, Clinical, and Prognostic Associations

Agoff, S. N., Swanson, P. E., Linden, H. M., Hawes, S. E., & Lawton, T. J. (2003) · American Journal of Clinical Pathology · doi:10.1309/42f0-0d0d-jd0j-5edt · Cited by 211 · see citing works

Androgen Receptor Expression in Estrogen Receptor–Negative Breast Cancer

Agoff, S. N., Swanson, P. E., Linden, H. M., Hawes, S. E., & Lawton, T. J. (2003) · American Journal of Clinical Pathology · doi:10.1309/42f00d0djd0j5edt · Cited by 205 · see citing works

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

Ogawa, Y., Hai, E., Matsumoto, K., Ikeda, K., Tokunaga, S., Nagahara, H., Sakurai, K., Inoue, T., & Nishiguchi, Y. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0770-6 · Cited by 183 · see citing works

Role of Androgens on MCF-7 Breast Cancer Cell Growth and on the Inhibitory Effect of Letrozole

Macedo, L. F., Guo, Z., Tilghman, S. L., Sabnis, G. J., Qiu, Y., & Brodie, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3984 · Cited by 159 · see citing works

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

Isola, J. J. (1993) · The Journal of Pathology · doi:10.1002/path.1711700106 · Cited by 157 · see citing works

Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-like Syndrome

Bennett, K. L. (2010) · JAMA · doi:10.1001/jama.2010.1877 · Cited by 153 · see citing works

Effects of Long Term Androgen and Estradiol Exposure on the Hypothalamus*

Brawer, J. R., Schipper, H. M., & Robaire, B. (1983) · Endocrinology · doi:10.1210/endo-112-1-194 · Cited by 131 · see citing works

Breast cancer: from estrogen to androgen receptor

Andò, S., Amicis, F. D., Rago, V., Carpino, A., Maggiolini, M., Panno, M., & Lanzino, M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00105-3 · Cited by 130 · see citing works

Androgen-Induced Inhibition of Proliferation in Human Breast Cancer MCF7 Cells Transfected with Androgen Receptor

Szelei, J., Jiménez, J., Soto, A. M., Luizzi, M. F., & Sonnenschein, C. (1997) · Endocrinology · doi:10.1210/endo.138.4.5047 · Cited by 130 · see citing works

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

Kandouz, M., Lombet, A., Jy, P., Jacob, D., Carvajal‐Gonzalez, S., Kazem, A. H., Rostène, W. H., Therwath, A., & Gompel, A. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00069-2 · Cited by 129 · see citing works

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation

Ghosh, P., Malik, S. N., Bedolla, R. G., Wang, Y., Mikhailova, M., Prihoda, T. J., Troyer, D. A., & Kreisberg, J. I. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00835 · Cited by 110 · see citing works

Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.

Søreide, J. A., Lea, O. A., Varhaug, J. E., Skarstein, A., & Kvinnsland, S. (1992) · PubMed · Cited by 105 · see citing works

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

Wang, Y., Михайлова, М. А., Bose, S., Pan, C.-X., White, R. D., & Ghosh, P. (2008) · Oncogene · doi:10.1038/onc.2008.318 · Cited by 104 · see citing works

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers

Wang, Y., Romigh, T., He, X., Tan, M.-H., Orloff, M., Silverman, R. H., Heston, W. D. W., & Eng, C. (2011) · Oncogene · doi:10.1038/onc.2011.144 · Cited by 96 · see citing works

Transcriptional Regulation of Estrogen Receptor-α by p53 in Human Breast Cancer Cells

Shirley, S. H., Rundhaug, J. E., Tian, J., Cullinan-Ammann, N., Lambertz, I. U., Conti, C. J., & Fuchs‐Young, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3628 · Cited by 95 · see citing works

Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element

Lanzino, M., Sisci, D., Morelli, C., Garofalo, C., Catalano, S., Casaburi, I., Capparelli, C., Giordano, C., Giordano, F., Maggiolini, M., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq278 · Cited by 90 · see citing works

Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene

Bièche, I. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1521 · Cited by 87 · see citing works

Killin is a p53-regulated nuclear inhibitor of DNA synthesis

Cho, Y., & Liang, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705410105 · Cited by 84 · see citing works

A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells

Wang, Y., Kreisberg, J. I., Bedolla, R. G., Михайлова, М. А., White, R. D., & Ghosh, P. (2007) · Oncogene · doi:10.1038/sj.onc.1210435 · Cited by 81 · see citing works

Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-α-positive and -negative breast cancer cells

Lin, H., Sun, M., Lin, C., Tang, H.-Y., London, D., Shih, A., Davis, F. B., & Davis, P. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.010 · Cited by 81 · see citing works

Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1)

Greeve, M., Allan, R. K., Harvey, J. A., & Bentel, J. M. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320793 · Cited by 78 · see citing works

Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis

Kampa, M., Nifli, A., Charalampopoulos, I., Alexaki, V. I., Theodoropoulos, P. A., Stathopoulos, E. N., Gravanis, A., & Castanas, E. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.027 · Cited by 72 · see citing works

GATA2 negatively regulates PTEN by preventing nuclear translocation of androgen receptor and by androgen-independent suppression of PTEN transcription in breast cancer

Wang, Y., He, X., Ngeow, J. Y. Y., & Eng, C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr491 · Cited by 71 · see citing works

Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer ZR-75-1 cells.

de Launoit, Y., Dauvois, S., Dufour, M., Simard, J., & Labrie, F. (1991) · PubMed · Cited by 59 · see citing works

An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity

Moore, N. L. T., Buchanan, G., Harris, J. M., Selth, L. A., Bianco‐Miotto, T., Hanson, A. R., Birrell, S. N., Butler, L. M., Hickey, T. E., & Tilley, W. D. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0065 · Cited by 55 · see citing works

Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation

Lapointe, J., & Labrie, C. (2001) · Endocrinology · doi:10.1210/endo.142.10.8417 · Cited by 30 · see citing works

Altered brain and pituitary androgen metabolism by prenatal, perinatal or pre- and postnatal finasteride, flutamide or dihydrotestosterone treatment in juvenile male rats

Lephart, E. D., & Husmann, D. A. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90026-o · Cited by 27 · see citing works

Analysis of KLLN as a high-penetrance breast cancer predisposition gene

kConFab, Thompson, E. R., Gorringe, K. L., Choong, D. Y. H., Eccles, D., Mitchell, G., & Campbell, I. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2088-3 · Cited by 6 · see citing works

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

Gerratana, L., Basile, D., Buono, G., Placido, S. D., Giuliano, M., Minichillo, S., Coinu, A., Martorana, F., Santo, I. D., Mastro, L. D., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.06.005 · Cited by 287 · see citing works

Complexities of androgen receptor signalling in breast cancer

McNamara, K. M., Moore, N. L. T., Hickey, T. E., Sasano, H., & Tilley, W. D. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0243 · Cited by 134 · see citing works

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines

Rizza, P., Barone, I., Zito, D., Giordano, F., Lanzino, M., Amicis, F. D., Mauro, L., Sisci, D., Catalano, S., Wright, K. D., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3619 · Cited by 114 · see citing works

Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms

Feng, J., Li, L., Zhang, N., Liu, J., Zhang, L., Gao, H., Wang, G., Li, Y., Zhang, Y., Li, X., et al. (2016) · Oncogene · doi:10.1038/onc.2016.432 · Cited by 109 · see citing works

A Linkage Between Thyroid and Breast Cancer: A Common Etiology?

Bolf, E. L., Sprague, B. L., & Carr, F. E. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0877 · Cited by 103 · see citing works

Integrative multi-omics module network inference with lemon-tree

Bonnet, E., Calzone, L., & Michoel, T. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003983 · Cited by 98 · see citing works

Altered genome-wide methylation in endometriosis

Naqvi, H., Ilagan, Y., Krikun, G., & Taylor, H. S. (2014) · Reproductive Sciences · doi:10.1177/1933719114532841 · Cited by 82 · see citing works

The intracrinology of breast cancer

McNamara, K. M., & Sasano, H. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.004 · Cited by 70 · see citing works

LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis

Hu, J., Huang, H., Xi, Z., Ma, S., Ming, J., Dong, F., Guo, H., Zhang, H., Zhao, E., Yao, G., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05189-7 · Cited by 59 · see citing works

XTEN as Biological Alternative to PEGylation Allows Complete Expression of a Protease-Activatable Killin-Based Cytostatic

Haeckel, A., Appler, F., de Schellenberger, A. A., & Schellenberger, E. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157193 · Cited by 39 · see citing works

Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer

Kim, D., Li, R., DUDEK, S. M., & Ritchie, M. D. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.05.019 · Cited by 36 · see citing works

Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer

Gao, F., Wu, Y., Wang, R., Yao, Y., Liu, Y., Fan, L., Xu, J., Zhang, J., Han, X., & Guan, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.012 · Cited by 31 · see citing works

KLLN epigenotype–phenotype associations in Cowden syndrome

Nizialek, E. A., Mester, J. L., Dhiman, V. K., Smiraglia, D. J., & Eng, C. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.8 · Cited by 30 · see citing works

Upregulated microRNA-224 promotes ovarian cancer cell proliferation by targeting KLLN

Hu, K., & Liang, M. (2016) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-016-0093-2 · Cited by 28 · see citing works

Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation

Wang, Y., Yu, Q., He, X., Romigh, T., Altemus, J. B., & Eng, C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0655 · Cited by 26 · see citing works

Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth

Zhang, B., Hu, X., Wang, X., Thériault, J.-F., Zhu, D., Shang, P., Labrie, F., & Lin, S. (2016) · Biochemical Journal · doi:10.1042/bcj20160083 · Cited by 25 · see citing works

KSRP modulates melanoma growth and efficacy of vemurafenib

Liu, W., Chou, C., Liu, S., Crossman, D. K., Yusuf, N., Wu, Y., & Chen, C. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.06.005 · Cited by 21 · see citing works

17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer

Hashimoto, C., Miki, Y., Tanaka, S., Takagi, K., Fue, M., Do.e, Z., Li, B., Yaegashi, N., Suzuki, T., & Ito, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041139 · Cited by 22 · see citing works

PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?

Yehia, L., & Eng, C. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa127 · Cited by 21 · see citing works

The Other Side of the Coin: May Androgens Have a Role in Breast Cancer Risk?

Chiodo, C., Morelli, C., Cavaliere, F., Sisci, D., & Lanzino, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010424 · Cited by 19 · see citing works

KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cells

Sankunny, M., & Eng, C. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0094-x · Cited by 19 · see citing works

Androgen blockade based clinical trials landscape in triple negative breast cancer

Shi, Y., Yang, F., Huang, D., & Guan, X. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.05.004 · Cited by 19 · see citing works

p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells

Luo, D., Yu, C., Yu, J., Su, C., Li, S., & Liang, P. (2021) · Cell Cycle · doi:10.1080/15384101.2021.2014249 · Cited by 18 · see citing works

The TP73 complex network: Ready for clinical translation in cancer?

Soldevilla, B., Millán, C. S., Bonilla, F., & Domínguez, G. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22095 · Cited by 18 · see citing works

Cancer-predisposition geneKLLNmaintains pericentric H3K9 trimethylation protecting genomic stability

Nizialek, E. A., Sankunny, M., Niazi, F., & Eng, C. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1481 · Cited by 18 · see citing works

Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?

Razavi, S. A., Modarressi, M. H., Yaghmaei, P., Tavangar, S. M., & Hedayati, M. (2017) · Endocrine · doi:10.1007/s12020-017-1368-4 · Cited by 18 · see citing works

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy

Hu, T., Liu, Y., Wu, J., Hu, X. L., Zhao, G., Liang, B., Wang, S., & Long, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061607 · Cited by 17 · see citing works

Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions

Lu, M., Liu, H., Zheng, B., Sun, S., & Chen, C. (2022) · Cancers · doi:10.3390/cancers14205117 · Cited by 16 · see citing works

MicroRNA‑204 may participate in the pathogenesis of hypoxic‑ischemic encephalopathy through targeting KLLN

Chen, R., Wang, M., Fu, S., Cao, F., Duan, P.-K., & Lu, J. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7936 · Cited by 15 · see citing works

EBF2 Links KMT2D‐Mediated H3K4me1 to Suppress Pancreatic Cancer Progression via Upregulating KLLN

Yao, B., Xing, M., Meng, S., Li, S., Zhou, J., Zhang, M., Yang, C., Qu, S., Jin, Y., Yuan, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202302037 · Cited by 14 · see citing works

Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes

Shukla, N., Shah, K., Rathore, D., Soni, K., Shah, J., Vora, H., & Dave, H. V. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122697 · Cited by 15 · see citing works

New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinoma

Razavi, S. A., Salehipour, P., Gholami, H., Sheikholeslami, S., Zarif-Yeganeh, M., Yaghmaei, P., Modarressi, M. H., & Hedayati, M. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153586 · Cited by 12 · see citing works

C1orf64 is a novel androgen receptor target gene and coregulator that interacts with 14-3-3 protein in breast cancer

Naderi, A. (2017) · Oncotarget · doi:10.18632/oncotarget.17826 · Cited by 12 · see citing works

Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells

Rangel, N., Villegas, V. E., & Rondón‐Lagos, M. (2021) · Cancers · doi:10.3390/cancers13092218 · Cited by 11 · see citing works

Significant role and mechanism of microRNA-143-3p/KLLN axis in the development of coronary heart disease.

Liu, H., Xiong, W., Liu, F., Lin, F., He, J., Liu, C., Lin, Y., & Dong, S. (2019) · Europe PMC (PubMed Central) · Cited by 10 · see citing works

Role of androgen and microRNA in triple-negative breast cancer

Al-Othman, N., Ahram, M. A., & Alqaraleh, M. (2019) · Breast Disease · doi:10.3233/bd-190416 · Cited by 10 · see citing works

Intrinsic Subtypes and Androgen Receptor Gene Expression in Primary Breast Cancer. A Meta-Analysis

Cruz‐Tapias, P., Rubiano, W., Rondón‐Lagos, M., Villegas, V. E., & Rangel, N. (2021) · Biology · doi:10.3390/biology10090834 · Cited by 10 · see citing works

Androgen Receptor as a Potential Target for Treatment of Breast Cancer

Wu, Y. (2017) · International Journal of Cancer Research and Molecular Mechanisms · doi:10.16966/2381-3318.129 · Cited by 9 · see citing works

Effects of butyl benzyl phthalate exposure during pregnancy and lactation on the post-involution mammary gland

Mogus, J. P., Matouskova, K., Clark, Z. W., Jerry, D. J., & Vandenberg, L. N. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108470 · Cited by 9 · see citing works

circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR‐92a‐2‐5p/KLLN Pathway

Gao, L., Shao, X., Yue, Q., Wu, W., Yang, X., He, X., Li, L., Hou, F., & Zhang, R. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9970272 · Cited by 9 · see citing works

Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease

Philley, J. V., Hertweck, K. L., Kannan, A., Brown‐Elliott, B. A., Wallace, R. J., Kurdowska, A., Ndetan, H. T., Singh, K. P., Miller, E. J., Griffith, D. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29471-x · Cited by 8 · see citing works

Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer

Wang, X., Petrossian, K., Huang, M.-J., Saeki, K., Kanaya, N., Chang, G., Somlo, G., & Chen, S. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105791 · Cited by 7 · see citing works

Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality

Lin, S., Wang, Z., & Xing, M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad722 · Cited by 4 · see citing works

The Diagnostics of Disease Relapse Within Five-Year Follow-Up and the Role of Androgen Receptor Expression in Patients with Early Triple-Negative Breast Cancer

Spurnić, I., Šušnjar, S. V., Jovanić, I., Natasa, M.-M., Milovanović, Z., Popović, M., Bukumirić, Z., Gavrilović, D., Rajšić, S., & Marković, I. (2025) · Diagnostics · doi:10.3390/diagnostics15060692 · Cited by 3 · see citing works

Nuclear KLLN expression associates with improved relapse-free survival for prostate carcinoma

Wang, Y., Roma, A. A., Nolley, R., Abdul‐Karim, F. W., Peehl, D. M., & Eng, C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0148 · Cited by 3 · see citing works

t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies

Bernués, M., González, T., Corchete, L. A., dos Santos, S. M. C., Durán, M. A., Andrade, B. L., Riso, L. L., Martínez-Serra, J., Ramos, R. F., Iglesias, J., et al. (2022) · Cancer Genetics · doi:10.1016/j.cancergen.2022.03.004 · Cited by 3 · see citing works

Identification of nuclear export signal in KLLN suggests potential role in proteasomal degradation in cancer cells

Sankunny, M., & Eng, C. (2020) · Oncotarget · doi:10.18632/oncotarget.27833 · Cited by 3 · see citing works

Pituitary adenoma-induced IGF-I triggers increased proliferation and tumorigenic potential of thyroid cells by suppressing KLLN via MET/TP53 axis

Guo, X., Lei, Y. A. N. G., Zhong, J., Wu, B., Yang, C., Wu, J., Wang, X., Xie, Y., Zhang, R., Zhang, J., et al. (2026) · Experimental Cell Research · doi:10.1016/j.yexcr.2026.115009 · Cited by 1 · see citing works

Molecular Sub-Typing and Exploration of Key Signalling Pathways Involved in Complicating the Disease

Anto, N. P., Muraleedharan, A., & Mittal, R. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815079784123010006 · Cited by 1 · see citing works

Structure and biological function of human 3-alpha hydroxysteroid dehydrogenase type 3 in breast cancer

Zhang, B. (2014) · Corpus Université Laval (Université Laval)

The Role of Androgen Receptor Signalling in Endocrine Resistant Breast Cancer

Bryan, R. A. (2018) · Open Access at Essex (University of Essex)

Effect of crocin on PKHD1 and KLLN genes expression in kidney tissue of female rats treated with cadmium

Mohamdyari, A., Keshtmand, Z., & Moghaddam, N. A. (2020) · International Journal of Medical and Surgical Sciences · doi:10.32457/ijmss.v7i1.475

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Nizialek, E. A., Lessieur, E. M., & Eng, C. (2013)

BAP18, as a corepressor of AR together with the SIN3A/HDAC complex, promotes AR-positive triple-negative breast cancer progression

Zhang, Y., Jin, Z., Wu, Y. M., Tang, X., Wang, C., Wang, S., Li, Y., Zhang, T., Jin, F., Lu, H., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01489-5

Role of ERβ in Triple-Negative Breast Cancer Associated with p53 and Androgen Receptor

Ito, K., Honma, N., Ogata, H., Yamada, A., Miyashita, M., Arai, T., Sasaki, E., Shibuya, K., Mikami, T., & Sawaki, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311459

Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications

Zeng, K., Wang, A.-Q., Sun, H.-M., Wang, C.-Y., Wang, S.-L., Zou, R.-L., Yang, D.-J., Bai, Y., Wang, M.-L., Xu, Y.-Y., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01568-x

Abstract 4855: KLLN, which shares a bidirectional promoter with PTEN, is an AR-regulated tumor suppressor, and induces p53-dependent and -independent apoptosis in breast cancer

Wang, Y., He, X., & Eng, C. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-4855

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers

Wang, Y., Romigh, T., He, X., Tan, M.-H., Orloff, M., Silverman, R. H., Heston, W. D. W., & Eng, C. (2011) · Oncogene · doi:10.1038/onc.2011.144 · Cited by 96 · see citing works

Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens

Takagi, K., Miki, Y., Onodera, Y., Nakamura, Y., Ishida, T., Watanabe, M., Inoue, S., Sasano, H., & Suzuki, T. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0017 · Cited by 49 · see citing works

New PTEN Signal Pathway in Breast Cancer

Chang, C. (2003) · doi:10.21236/ada418006

Kru¨ ppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgensPreprint

Muungo, L. (2020) · doi:10.31234/osf.io/85z23